Fact CheckerSign in

NCT07582497Not yet recruiting

Motor and Cognitive Telerehabilitation in a Virtual Environment in Patients With Post-stroke Sequelae and Parkinson's Disease

Telerehabilitation in a Virtual Environment for Sensorimotor and Cognitive Recovery in Patients With Post-stroke Sequelae and Parkinson's Disease: a Pilot Study

Source: ClinicalTrials.gov · Last updated 14 May 2026

Brief summary (registry, in English)

The goal of this interventional pilot trial is to evaluate whether a telerehabilitation protocol based on immersive virtual reality (VR) is effective and feasible for the recovery of cognitive and/or motor functions in patients with sequelae of ischemic or hemorrhagic stroke or with Parkinson's disease. The main questions it aims to answer are: * Does the VR-based telerehabilitation protocol improve cognitive and/or motor outcomes compared to conventional rehabilitation? * Is the protocol feasible, defined as ≥80% adherence among participants? Is the system acceptable and user-friendly from the patient's perspective? Researchers will compare an interventional arm receiving telerehabilitation via an immersive VR home kit with a control arm receiving conventional rehabilitation according to standard clinical practice. Both groups will receive the same number of sessions, with the same duration and weekly frequency. Outcomes will be assessed at baseline (T0), after 4 weeks of treatment (T1), and at 3-month follow-up (T2).

Status (registry)
Not yet recruiting
Study type
Interventional
Enrollment
60 (estimated)
First submitted
17 Apr 2026
Start date
Jun 2026
Primary completion date
Jul 2026
Lead sponsor
Azienda Usl di Bologna
NCT number
NCT07582497

What you commit to

  • Study type: Interventional
  • Planned participants: 60
  • From Jun 2026 to the primary completion date, Jul 2026
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • important cognitive impairment;
  • psychiatric, neurological, or internal medicine comorbidities;

Other

  • ongoing clinical instability;
  • severe rigidity or hypertonia;
  • severe visual deficit;
  • pregnancy women

Who the study is looking for

  • Age \>18 years old, both sex;
  • stroke or Parkinson diagnosis \> or = 2 months;
  • upper limb impairment
  • informed consent signed

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
IRCCS Istituto delle Scienze Neurologiche di Bologna - AUSL of Bologna
Coordinator of this site? Confirm its status
BolognaItalyUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.